Amphastar Pharmaceuticals, Inc. SEC filings AMPH

Amphastar Pharmaceuticals, Inc. has 954 filings in SEC EDGAR's recent list, going back to Feb 11, 2005. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Amphastar Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Jul 13, 2026 Jul 9, 2026
8-K Current report
Other events
Jul 8, 2026 Jul 2, 2026
8-K Current report
Shareholder vote results
Jun 3, 2026 Jun 1, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 13, 2026 —
DEF 14A Proxy statement Apr 13, 2026 Jun 1, 2026
8-K Current report
Other events
Mar 16, 2026 Mar 12, 2026
8-K Current report
Officer or director change
Mar 6, 2026 Mar 3, 2026
8-K Current report
Material agreement
Mar 6, 2026 Mar 3, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jan 12, 2026 Jan 6, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Material agreement
Oct 24, 2025 Oct 21, 2025
8-K Current report
Material agreement
Sep 18, 2025 Sep 15, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 12, 2025 Aug 8, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change
Jul 21, 2025 Jul 18, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2025 Jun 2, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 14, 2025 —
DEF 14A Proxy statement Apr 14, 2025 Jun 2, 2025
PRE 14A Preliminary proxy statement Apr 2, 2025 Jun 2, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Material agreement
Aug 30, 2024 Aug 28, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 4, 2024 Jun 3, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
DEFA14A Additional proxy material Apr 19, 2024 —
ARS Annual report to shareholders Apr 12, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 12, 2024 —
DEF 14A Proxy statement Apr 12, 2024 Jun 3, 2024
S-8 Employee stock plan registration Feb 29, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Sep 15, 2023 Sep 11, 2023
8-K/A Amended current report Aug 16, 2023 Jun 30, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Other events
Jun 30, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 6, 2023 Jun 5, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Material agreement, New debt, Other events
Apr 24, 2023 Apr 21, 2023
ARS Annual report to shareholders Apr 14, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 14, 2023 —
DEF 14A Proxy statement Apr 14, 2023 —
8-K Current report
Material agreement
Mar 10, 2023 Mar 8, 2023
S-8 Employee stock plan registration Mar 1, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Bylaw or fiscal year change
Feb 24, 2023 Feb 23, 2023
8-K Current report
Material agreement
Nov 18, 2022 Nov 15, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Officer or director change
Aug 9, 2022 Aug 4, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Material agreement
Jul 8, 2022 Jul 5, 2022
8-K Current report
Shareholder vote results
Jun 13, 2022 Jun 10, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
8-K Current report
Material agreement
Apr 22, 2022 Apr 19, 2022
DEFA14A Additional proxy material Apr 14, 2022 —
DEF 14A Proxy statement Apr 14, 2022 Jun 10, 2022
S-8 Employee stock plan registration Mar 11, 2022 —
10-K Annual report Mar 11, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
EFFECT Filing Nov 19, 2021 —
CORRESP Letter to the SEC Nov 17, 2021 —
UPLOAD Letter from the SEC Nov 15, 2021 —
S-3 Shelf registration Nov 9, 2021 —
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Officer or director change
Aug 23, 2021 Aug 19, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change
Aug 20, 2021 Aug 19, 2021
8-K Current report
Officer or director change
Aug 10, 2021 Aug 5, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Material agreement, Agreement ended, New debt
Aug 9, 2021 Aug 4, 2021
8-K Current report
Shareholder vote results
Jun 8, 2021 Jun 7, 2021
DEFA14A Additional proxy material May 7, 2021 —
10-Q Quarterly report May 7, 2021 Mar 31, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
May 7, 2021 May 6, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 14, 2021 —
DEF 14A Proxy statement Apr 14, 2021 Jun 7, 2021
S-8 Employee stock plan registration Mar 15, 2021 —
10-K Annual report Mar 15, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 15, 2021 Mar 15, 2021
8-K Current report
Regulation FD disclosure
Jan 12, 2021 Jan 12, 2021
8-K Current report
Officer or director change, Other events
Nov 6, 2020 Nov 3, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 6, 2020 Nov 6, 2020
8-K/A Amended current report
Shareholder vote results
Aug 10, 2020 Jun 8, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Shareholder vote results
Jun 9, 2020 Jun 8, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 15, 2020 —
DEF 14A Proxy statement Apr 15, 2020 Jun 8, 2020
8-K/A Amended current report
Officer or director change
Apr 14, 2020 Apr 10, 2020
8-K Current report
Officer or director change
Apr 13, 2020 Apr 13, 2020
S-8 Employee stock plan registration Mar 16, 2020 —
10-K Annual report Mar 16, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 12, 2020 Mar 12, 2020
10-Q Quarterly report Nov 8, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Other events
Jun 19, 2019 Jun 19, 2019
8-K Current report
Shareholder vote results
Jun 13, 2019 Jun 12, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEFA14A Additional proxy material Apr 18, 2019 —
DEF 14A Proxy statement Apr 18, 2019 Jun 12, 2019
S-8 Employee stock plan registration Mar 15, 2019 —
10-K Annual report Mar 15, 2019 Dec 31, 2018
DEFA14A Additional proxy material Mar 15, 2019 —
8-K Current report
Officer or director change, Other events
Mar 14, 2019 Mar 14, 2019
8-K Current report
Results of operations
Mar 12, 2019 Mar 12, 2019
EFFECT Filing Nov 20, 2018 —
CORRESP Letter to the SEC Nov 16, 2018 —
UPLOAD Letter from the SEC Nov 15, 2018 —
S-3 Shelf registration Nov 9, 2018 —
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 8, 2018 Nov 8, 2018
8-K Current report
Other events
Nov 8, 2018 Nov 7, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 8, 2018 Aug 8, 2018
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Jul 9, 2018 Jul 2, 2018
8-K Current report
Shareholder vote results
Jun 8, 2018 Jun 7, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
DEFA14A Additional proxy material Apr 18, 2018 —
DEF 14A Proxy statement Apr 18, 2018 Jun 7, 2018
8-K Current report
Other events
Mar 21, 2018 Mar 21, 2018
S-8 Employee stock plan registration Mar 14, 2018 —
10-K Annual report Mar 14, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 12, 2018 Mar 12, 2018
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 8, 2017 Nov 8, 2017
10-Q Quarterly report Aug 9, 2017 Jun 30, 2017
8-K Current report
Results of operations
Aug 9, 2017 Aug 9, 2017
8-K Current report
Other events
Jul 24, 2017 Jul 24, 2017
8-K Current report
Shareholder vote results
Jun 9, 2017 Jun 8, 2017
10-Q Quarterly report May 10, 2017 Mar 31, 2017
8-K Current report
Results of operations
May 8, 2017 May 8, 2017
CT ORDER Filing Apr 26, 2017 —
DEFA14A Additional proxy material Apr 21, 2017 —
DEF 14A Proxy statement Apr 21, 2017 Jun 8, 2017
S-8 Employee stock plan registration Mar 15, 2017 —
10-K Annual report Mar 15, 2017 Dec 31, 2016
8-K Current report
Results of operations
Mar 13, 2017 Mar 13, 2017
8-K Current report
Other events
Dec 27, 2016 Dec 27, 2016
8-K Current report
Material agreement, Other events
Nov 10, 2016 Nov 9, 2016
10-Q Quarterly report Nov 9, 2016 Sep 30, 2016
8-K Current report
Results of operations
Nov 8, 2016 Sep 30, 2016
UPLOAD Letter from the SEC Nov 3, 2016 —
CORRESP Letter to the SEC Oct 14, 2016 —
UPLOAD Letter from the SEC Sep 27, 2016 —
10-Q Quarterly report Aug 9, 2016 Jun 30, 2016
8-K Current report
Results of operations
Aug 8, 2016 Aug 8, 2016
8-K Current report
Other events
Aug 4, 2016 Aug 1, 2016
8-K Current report
Material agreement, Agreement ended, Regulation FD disclosure
Jul 7, 2016 Jun 30, 2016
8-K Current report
Shareholder vote results
Jun 10, 2016 Jun 9, 2016
10-Q Quarterly report May 10, 2016 Mar 31, 2016
8-K Current report
Results of operations
May 9, 2016 May 9, 2016
DEFA14A Additional proxy material Apr 22, 2016 —
DEF 14A Proxy statement Apr 22, 2016 Jun 9, 2016
S-8 Employee stock plan registration Mar 15, 2016 —
10-K Annual report Mar 15, 2016 Dec 31, 2015
8-K Current report
Results of operations
Mar 14, 2016 Mar 14, 2016
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
8-K Current report
Results of operations
Nov 12, 2015 Nov 12, 2015
10-Q Quarterly report Aug 13, 2015 Jun 30, 2015
8-K Current report
Results of operations
Aug 12, 2015 Aug 12, 2015
EFFECT Filing Jul 17, 2015 —
CORRESP Letter to the SEC Jul 14, 2015 —
UPLOAD Letter from the SEC Jul 10, 2015 —
S-8 Employee stock plan registration Jul 2, 2015 —
S-3 Shelf registration Jul 2, 2015 —
8-K Current report
Other events
Jun 22, 2015 Jun 22, 2015
8-K Current report
Officer or director change, Shareholder vote results
Jun 1, 2015 May 27, 2015

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AMPH (Nasdaq)
Fiscal year ends
December 31
Headquarters
Rancho Cucamonga, CA
SEC filer status
Large accelerated filer
SEC CIK
1297184

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.